// App-Quantinova.ai

227 : Pharmacokinetic food-effect study of abiraterone acetate (AA) in patients with metastatic castration resistant prostate cancer (mCRPC): The ABIFOOD trial (EudraCt number: 2012-003226-25).

Researchers

Presenter

  • M. Espinosa

Principal Investigators

  • A Gutierrez-Valencia

  • A Cervera

  • CM Rosso-Fernandez

  • E Martinez-Lozano

  • B Perez-Valderrama

  • J Martinez-Atienza

  • L Jimenez Gonzalez-Serna

  • I Sanchez-Simon

  • M Cruz

  • A Rodriguez

  • JA Virizuela

  • P Maiquez

  • N Hindi

  • I Gallego Jimenez

  • FL Lopez-Cortes

  • Luis G. Paz-Ares

  • Ignacio Duran

Medical Centers

  • Medical Oncology Department. Hospital Universitario Virgen del Rocio, Seville, Spain

  • Medical Oncology Department. Hospital Universitario Virgen del Rocio, Seville, Spain

  • Institute of Biomedicine of Seville (IBIS), Seville, Spain

  • Medical Oncology Department. Hospital Universitario Virgen del Rocio, Seville, Spain

  • Clinical Research and Clinical Trials Unit. Hospital Universitario Virgen del Rocío, Seville, Spain

  • Medical Oncology Department. Hospital Universitario Virgen del Rocio, Seville, Spain

  • Medical Oncology Department. Hospital Universitario Virgen del Rocio, Seville, Spain

  • Medical Oncology Department. Hospital Universitario Virgen del Rocio, Seville, Spain

  • Institute of Biomedicine of Seville (IBIS), Seville, Spain

  • Hospital Universitario Doce de Octubre, Madrid, Spain

  • Hospital Universitario Virgen del Rocio, Sevilla, Spain

Locations

  • Spain

  • Sri Lanka

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Metastatic castration-resistant prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • CB-7598

  • Docetaxel

Outcome

  • N/A

Study Design

  • Randomized

  • Pharmacokinetics

Phase

  • I

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved